Structure

InChI Key ZKHQWZAMYRWXGA-KQYNXXCUSA-N
Smile Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O
InChI
InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C10H16N5O13P3
Molecular Weight 507.18
AlogP -1.63
Hydrogen Bond Acceptor 14.0
Hydrogen Bond Donor 7.0
Number of Rotational Bond 8.0
Polar Surface Area 279.13
Molecular species ACID
Aromatic Rings 2.0
Heavy Atoms 31.0

Pharmacology

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Alzheimer Disease 2 D000544 ClinicalTrials
Depressive Disorder, Major 2 D003865 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEBI 15422
ChEMBL CHEMBL14249
DrugBank DB00171
DrugCentral 91
EPA CompTox DTXSID6022559
FDA SRS 8L70Q75FXE
Human Metabolome Database HMDB0000538
Guide to Pharmacology 1713
KEGG C00002
PDB ATP
PharmGKB PA164743471
SureChEMBL SCHEMBL8979
ZINC ZINC000004261765